374 related articles for article (PubMed ID: 19075557)
1. Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction.
Bartoli ML; Di Franco A; Vagaggini B; Bacci E; Cianchetti S; Dente FL; Tonelli M; Paggiaro PL
Respiration; 2009; 77(3):265-72. PubMed ID: 19075557
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
3. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
Tsoumakidou M; Papadopouli E; Tzanakis N; Siafakas NM
Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
[TBL] [Abstract][Full Text] [Related]
4. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
6. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024
[TBL] [Abstract][Full Text] [Related]
7. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies.
Snoeck-Stroband JB; Lapperre TS; Gosman MM; Boezen HM; Timens W; ten Hacken NH; Sont JK; Sterk PJ; Hiemstra PS;
Eur Respir J; 2008 Jan; 31(1):70-7. PubMed ID: 17804442
[TBL] [Abstract][Full Text] [Related]
8. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.
Keatings VM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):449-53. PubMed ID: 9032177
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
[TBL] [Abstract][Full Text] [Related]
11. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
Brightling CE; Ward R; Woltmann G; Bradding P; Sheller JR; Dworski R; Pavord ID
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):878-82. PubMed ID: 10988099
[TBL] [Abstract][Full Text] [Related]
12. [The significance of inflammatory markers in sputum of asthmatic and chronic obstructive pulmonary diseases patients before and after glucocorticoid treatment].
Ma M; Fan W; Sun B; Li H
Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):181-3. PubMed ID: 11798648
[TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
14. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
Peng H; Chen P; Cai S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
[TBL] [Abstract][Full Text] [Related]
15. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
16. Proportional classifications of COPD phenotypes.
Marsh SE; Travers J; Weatherall M; Williams MV; Aldington S; Shirtcliffe PM; Hansell AL; Nowitz MR; McNaughton AA; Soriano JB; Beasley RW
Thorax; 2008 Sep; 63(9):761-7. PubMed ID: 18728201
[TBL] [Abstract][Full Text] [Related]
17. Protein networks in induced sputum from smokers and COPD patients.
Baraniuk JN; Casado B; Pannell LK; McGarvey PB; Boschetto P; Luisetti M; Iadarola P
Int J Chron Obstruct Pulmon Dis; 2015; 10():1957-75. PubMed ID: 26396508
[TBL] [Abstract][Full Text] [Related]
18. [Eotaxin in induced sputum in patients with asthma and chronic bronchitis: relationship with airway inflammation].
Fu J; Chen P; Xiang X
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jan; 25(1):29-32. PubMed ID: 11953096
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
